Mechano Growth Factor (MGF) — Dosing & Research | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Mechano Growth Factor (MGF)

Also known as: MGF, IGF-1Ec, IGF-1Eb (rodent), Mechano Growth Factor E peptide, MGF E peptide, MGF-24aa-E peptide, Full-length MGF, Goldspink-MGF, MGF R23H (variant)

IGF-1 splice variant / peptide growth factor (IGF superfamily)

Research chemicalLast updated: October 19, 2026Based on 18 peer-reviewed studies

What it is

MGF is a peptide people use to support muscle repair and growth after exercise or injury, based on its role as a natural healing signal in muscle tissue. It's also studied for bone and cartilage repair. Not FDA-approved; prohibited by WADA; evidence comes largely from animal and cell studies.

The scientific side

Mechano Growth Factor (MGF) is an isoform of insulin-like growth factor 1 (IGF-1) produced by differential/alternative splicing of the IGF-1 gene. A 49-base-pair insert in exon 5 (humans; 52 bp in rodents) introduces a reading frame shift, resulting in a unique C-terminal E-domain peptide with properties distinct from systemic IGF-IEa. MGF is expressed in response to mechanical stimulation, exercise, and tissue damage in skeletal muscle and other tissues. The E-domain peptide acts as a separate growth factor: it activates mononucleated satellite (stem) cells, promotes cell proliferation, and inhibits terminal differentiation of myoblasts. Full-length MGF directly activates the IGF-I receptor (IGF-IR), though with a higher EC50 than recombinant IGF-I; at high equimolar concentrations its maximal IGF-IR stimulating effect is similar to IGF-I. MGF also activates insulin receptor isoforms IR-A and IR-B. The MGF E peptide exerts anti-apoptotic effects, including via mitochondrial, MEK-ERK1/2, and PI3K-Akt pathways, and acts as a stem cell homing factor. MGF expression declines with aging and is deficient in muscular dystrophies where the mechanotransduction mechanism (possibly involving the dystrophin complex) is impaired.

Class: IGF-1 splice variant / peptide growth factor (IGF superfamily)

Administration & storage

Administration
Injection into rabbit bone defect model (exact route not specified in abstract) (PMID: 32339623)Scaffold implantation (subcutaneous and intra-articular) in rabbit models (PMID: 25818452)In vitro delivery via PEGDMA microrod devices (PMID: 24908137)In vitro addition to cell culture medium (PMID: 22592456PMID: 26991004)
Storage
No storage conditions for MGF peptide or protein are described in the reviewed literature.
Cautions
No human pharmacokinetic, safety, or tolerability data for MGF peptide or full-length MGF are reported in the reviewed literature. Human use lacks clinical evidence.,MGF R23H variant has been identified in confiscated vials from illicit channels; purity, sterility, and actual content of such products cannot be verified (PMID: 28035768, PMID: 25466910).,MGF (and full-length MGF) is classified as a prohibited substance by WADA since 2005; use in athletes constitutes a doping violation.,In vitro data show MGF peptide inhibits macrophage phagocytosis and ROS generation; potential immunosuppressive effects at certain concentrations are not well characterized in humans.,Sterile technique is essential for any injectable preparation; compounded or illicitly sourced peptides carry contamination and dosing accuracy risks.

Legal & regulatory status

US FDA

Not stated in reviewed literature — requires manual verification

WADA

Prohibited. The substance (or class of substances) has been considered prohibited according to the regulations of the World Anti-Doping Agency (WADA) since 2005.

Health Canada

Not stated in reviewed literature — requires manual verification